Jump Financial’s ARS Pharmaceuticals SPRY Stock Holding History

Jump Financial’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Buy	+255,200	New	+$2.2M	0.02%	894
2023 Q3	–	Sell	-111,900	Closed	-$750K	–	2232
2023 Q2	$750K	Buy	111,900 +73,810	+194%	+$493K	0.03%	828
2023 Q1	$248K	Sell	38,090 -1,987	-5%	-$15.3K	0.01%	1210
2022 Q4	$342K	Buy	+40,077	New	+$260K	0.02%	967
2022 Q1	–	Sell	-37,800	Closed	-$252K	–	1888
2021 Q4	$252K	Buy	37,800 +5,300	+16%	+$43.1K	0.02%	986
2021 Q3	$324K	Buy	+32,500	New	+$801K	0.02%	627

Other funds holding SPRY

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jump Financial's SPRY Position: Q2 2026 in Review

Jump Financial opened a new position in ARS Pharmaceuticals (SPRY) in Q2 2026: 255,200 shares worth $2.04M. The stake represents 0.02% of the portfolio and ranks #894 among its holdings. This is a return to the name: Jump Financial previously reported a position in SPRY as recently as Q2 2023.

Jump Financial first reported a position in SPRY in Q3 2021 and has held it in 6 quarters since. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

Jump Financial held 255,200 shares of ARS Pharmaceuticals worth $2.04M as of Q2 2026.
ARS Pharmaceuticals was a new Jump Financial position in Q2 2026.
ARS Pharmaceuticals made up 0.02% of Jump Financial's portfolio in Q2 2026, its #894 holding.
Jump Financial first reported a position in ARS Pharmaceuticals in Q3 2021 and has held it in 6 quarters since.
209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.